Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
-4.08M
-
Total reported value, excl. options
-
$417M
-
Value change
-
-$42.2M
-
Put/Call ratio
-
0.36
-
Number of buys
-
53
-
Number of sells
-
-60
-
Price
-
$11.19
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2016
149 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2016.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 58.9M outstanding shares and own 63.27% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT CO (6M shares), Palo Alto Investors, LLC (4.23M shares), PAULSON & CO. INC. (3.86M shares), GREAT POINT PARTNERS LLC (2.71M shares), MORGAN STANLEY (1.9M shares), VANGUARD GROUP INC (1.61M shares), MACQUARIE GROUP LTD (1.53M shares), BlackRock Fund Advisors (1.52M shares), STATE STREET CORP (1.29M shares), and BlackRock Institutional Trust Company, N.A. (1.11M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.